
Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection
Keywords: ویروس دنگی; Dengue virus; DNA vaccine; Adjuvant; Granulocyte-macrophage colony-stimulating factor;